Conference countdown: ask the e-Learning expert

The 57th Annual Meeting of the European Association for the Study of Diabetes (EASD) opens tomorrow. Once again, this year’s conference will be virtual – and there are some new ‘live’ twists to tempt you in too.
Last year over 20,000 registered delegates attended the EASD’s first ever Virtual EASD Annual Meeting – with a whopping 85,500 livestream views during the conference and over half a million webcast views of conference content made available after the Annual Meeting had taken place. This year’s conference promises to be even bigger, with several new tempting features on offer.
The traditional feast of symposia, oral presentations sessions and debates are all there, of course (check out the conference programme for details, https://www.easd.org/annual-meeting/easd-2021.html). Plus the landmark prize lectures that always feature among the Annual Meeting’s highlights. But this year offers some new features that take full advantage of the virtual nature of the conference. A new format takes the place of the usual poster presentations. Short, prerecorded PowerPoint presentations are available for delegates to view in advance, which can then be discussed during the conference in short oral discussion sessions.
And e-Learning itself has now been given a more prominent role – it even has its own parallel track within the conference programme. From Wednesday to Friday, delegates are able to attend live presentations by several of EASD e-Learning’s most distinguished authors and presenters, with real-time Q&A sessions so you can put your own questions to our authors. Many of these live events will be linked to launches of new content – including five new modules (see below for the complete programme of live events and launches).
Psst… big news alert!
If you are attending the virtual Annual Meeting, make sure to watch EASD President Stefano Del Prato’s address at the Opening Ceremony (Tuesday 28th September in the Moscow Hall at 10 am [CET]). Stefano will be announcing some very exciting news about the e-Learning platform and what we will be able to offer our users in the future.
Our content will also feature prominently in the footage being aired throughout the conference on EASD TV. If you tune in, watch out for the launches of some new film series from EASD e-Learning – including ‘Insulin in my country’ and ‘5 things we don’t yet know’ (we will be reporting more on those launches on Horizons this Wednesday).
And don’t forget to visit us at our conference stand in the Exhibition Hall. Our stand will be displaying lots of exciting materials to help you get to know more of what we currently offer and what we plan to offer you in the future.
EASD e-Learning live sessions during the Annual Meeting
To join the discussion with our authors and ask any questions you may have on their topic, don’t miss the following sessions.
Wednesday 29th September, Milan Hall
10.00-11.30 CET. Insulin@100: insulin in kids
Author: Carine de Beaufort
12.00-13.30 CET. New module launch: Fear of hypoglycaemia
Author: Frank Snoek
14.00-15.30 CET. New module launch: NAFLD – prevention and treatment
Author: Michael Roden
16.15-17.30 CET. Insulin@100: insulin and exercise
Author: Mike Riddell
Thursday 30th September, Milan Hall
10.00-11.30 CET. New module launch: Obesity and the pathogenesis and outcomes of type 2 diabetes
Author: Naveed Sattar
12.00-13.30 CET. Insulin@100: insulin, GLP-1RAs and fixed-ratio combinations
Author: Tina Vilsbøll
14.00-15.30 CET. New module launch: Pathophysiology and treatment of painful diabetic neuropathy
Author: Solomon Tesfaye
16.00-17.30 CET. Insulin@100: insulin in hospital settings
Author: Guillermo Umpierrez
Friday 1st October, Milan Hall
10.00-11.30 CET. Insulin@100: physiological insulin replacement
Author: Eelco de Koning
12.00-13.30 CET. The long and the short of it: novel technologies
Authors: Tadej Battelino and Moshe Philip
14.00-15.30 CET. New module launch: Real-world evidence
Author: Marc Evans
The opinions expressed in this article are those of the author, Dr Eleanor D Kennedy.